To ensure that people are not only treated when they are ill, but that diseases do not develop in the first place, medicine must systematically incorporate preventive measures. The BIH Biomedical Innovation Academy (BIA) and Charité – Universitätsmedizin Berlin are launching their Advanced Clinician…
Since the last certificate award ceremony at the International Clinician Scientist Symposium (June 2024), more than 60 program participants have completed their BIH Charité (Junior) (Digital) (Advanced) Clinician Scientist training. This means that the alumni community continues to grow – we are…
This year, the retreat took us and around 150 participants to the “Villa Elisabeth” in Berlin Mitte for an inspiring day. The aim of the one-day CSP retreat was to strengthen the interdisciplinary networking of the fellows. The (Junior) (Digital) Clinician Scientists helped design the program from…
The Coalition for Advancing Research Assessment (CoARA) is awarding the Berlin Institute of Health at Charité nearly €60,000 to advance the development of a transparent and fair infrastructure for evaluating research groups. To this end, BIH researchers are expanding the existing MERIT portal for…
The Berlin Institute of Health at Charité (BIH) bids farewell to Prof. Dr. Ulrich Dirnagl, honoring him as a central driving force for trustworthy and useful research upon his retirement. The internationally recognized stroke researcher and advocate of responsible science has shaped the biomedical…
Over 130 researchers and change-makers gathered from 22 to 24 September in Berlin for RRiA Unconference 2025, a three-day event driving transformation in research culture. With inspiring talks, hands-on projects, and vibrant networking, participants united to rethink and improve how science is done…
In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up…
